Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161610
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2023-11-21
Brief Title:
Recurrent High Grade Glioma Treated by LITT
Sponsor:
Beijing Tiantan Hospital
Organization:
Beijing Tiantan Hospital
Study Overview
Official Title:
Randomized Clinical Trial of Efficiency and Safety of Recurrent High Grade Glioma Treated by Laser Interstitial Thermal Therapy
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REGALITT
Brief Summary:
This clinical trial aims to investigate the efficiency and safety of laser interstitial thermal therapy LITT in recurrent high-grade glioma rHGG patients
The main questions it aims to answer are
The LITT would increase the progression-free survival and overall survival of rHGG patients compared to other treatments
The LITT is safe and applicable to rHGG patients Participants will be randomized to the intervention group LITT or control group at a ratio of 21 The intervention group patients will receive LITT The control group will be treated with any other treatment
The primary outcome of this trial is progression-free survival The estimated sample size is 135 90 in the LITT group and 45 in the control group
The main questions it aims to answer are
The LITT would increase the progression-free survival and overall survival of rHGG patients compared to other treatments
The LITT is safe and applicable to rHGG patients Participants will be randomized to the intervention group LITT or control group at a ratio of 21 The intervention group patients will receive LITT The control group will be treated with any other treatment
The primary outcome of this trial is progression-free survival The estimated sample size is 135 90 in the LITT group and 45 in the control group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None